Database Description

EMBASE® (Excerpta Medica)

Content
EMBASE has long been recognized as an important, comprehensive index of the world's literature on human medicine and related disciplines. About 370,000 records are added annually, over 75% of which contain abstracts. Each record is classified and indexed by medical research specialists who assign terms and codes in accordance with EMTREE, a highly developed classification schedule and controlled vocabulary, consisting of over 37,000 terms and 150,000 synonyms. EMBASE contains records from January 1974 to the present.

The EMBASE database is used to produce 41 print abstract bulletins and one print drug literature bibliography. All journal articles are added to the database within 20 days after receipt of the journal, and all records appear online with complete indexing.

Sources
EMBASE provides access to periodical articles from more than 2,900 primary journals from over 110 countries. An additional 600 journals are screened for drug articles.

Coverage

Dates Covered: January 1974 to the present
File Size: Over 6.9 million records as of December 1997
Update Frequency: Weekly

Provider
Elsevier Science B.V.
Secondary Publishing Division
Molenwerf 1
1014 AG Amsterdam
The Netherlands
Telephone: +31-6-022-6525 (The Netherlands)
+31-020-485-3507 (Elsewhere)
Fax: +31-20-485-3222

Elsevier Science
Secondary Publishing Division
245 W. 17th Street
New York, NY 10011
Telephone: 800-457-3633 (U.S., Canada, Puerto Rico, Virgin Islands)
212-633-3980
Fax: 212-633-3975
Elsevier Science Japan
Secondary Publishing Division
3-20-12 Yushima, Bunkyo-ku
Tokyo, 113
Japan
Telephone: +81-3-5688-4080
Fax: +81-3-3839-4344

Terms & Conditions The databases, created by Elsevier Science, B.V., are copyrighted by ES and all rights are reserved. ES REPRESENTS THAT EMBASE, THE DATABASE PROVIDED HEREUNDER, IS FORMULATED WITH A REASONABLE STANDARD OF CARE AND IN CONFORMANCE TO PROFESSIONAL STANDARDS IN THE FIELD. EXCEPT WITH RESPECT TO THE FOREGOING AND AS OTHERWISE SPECIFICALLY PROVIDED IN THIS AGREEMENT, ES MAKES NO REPRESENTATIONS OR WARRANTIES EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO SUCH DATABASE AND SPECIFICALLY DISCLAIMS ALL SUCH WARRANTIES AND REPRESENTATIONS. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, we recommend that independent verification of diagnoses and drug dosages should be made.

Content	EMBASE has long been recognized as an important, comprehensive index of the world's literature on human medicine and related disciplines. About 370,000 records are added annually, over 75% of which contain abstracts. Each record is classified and indexed by medical research specialists who assign terms and codes in accordance with EMTREE, a highly developed classification schedule and controlled vocabulary, consisting of over 37,000 terms and 150,000 synonyms. EMBASE contains records from January 1974 to the present. The EMBASE database is used to produce 41 print abstract bulletins and one print drug literature bibliography. All journal articles are added to the database within 20 days after receipt of the journal, and all records appear online with complete indexing.
Sources	EMBASE provides access to periodical articles from more than 2,900 primary journals from over 110 countries. An additional 600 journals are screened for drug articles.
Coverage	Dates Covered: January 1974 to the present File Size: Over 6.9 million records as of December 1997 Update Frequency: Weekly
Provider	Elsevier Science B.V. Secondary Publishing Division Molenwerf 1 1014 AG Amsterdam The Netherlands Telephone: +31-6-022-6525 (The Netherlands) +31-020-485-3507 (Elsewhere) Fax: +31-20-485-3222 Elsevier Science Secondary Publishing Division 245 W. 17th Street New York, NY 10011 Telephone: 800-457-3633 (U.S., Canada, Puerto Rico, Virgin Islands) 212-633-3980 Fax: 212-633-3975 Elsevier Science Japan Secondary Publishing Division 3-20-12 Yushima, Bunkyo-ku Tokyo, 113 Japan Telephone: +81-3-5688-4080 Fax: +81-3-3839-4344
Terms & Conditions	The databases, created by Elsevier Science, B.V., are copyrighted by ES and all rights are reserved. ES REPRESENTS THAT EMBASE, THE DATABASE PROVIDED HEREUNDER, IS FORMULATED WITH A REASONABLE STANDARD OF CARE AND IN CONFORMANCE TO PROFESSIONAL STANDARDS IN THE FIELD. EXCEPT WITH RESPECT TO THE FOREGOING AND AS OTHERWISE SPECIFICALLY PROVIDED IN THIS AGREEMENT, ES MAKES NO REPRESENTATIONS OR WARRANTIES EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO SUCH DATABASE AND SPECIFICALLY DISCLAIMS ALL SUCH WARRANTIES AND REPRESENTATIONS. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, we recommend that independent verification of diagnoses and drug dosages should be made.